Erythropoietin and erythropoiesis

Bert, 1882, Sur la richesse en hemoglobine du sang de animaux vivant sur les hauts, C R Acad Sci, 94, 805 Carnot, 1906, Sur l ‘activite’ hematopoietique des differents organs au cours de la regeneration du sang, C R Acad Sci, 143, 432 Grant, 1952, Fundamental stimulus for erythropoiesis, Physiol Rev, 32, 449, 10.1152/physrev.1952.32.4.449 Reissman, 1950, Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia, Blood, 5, 372, 10.1182/blood.V5.4.372.372 Erslev, 1953, Humoral regulation of red cell production, Blood, 8, 349, 10.1182/blood.V8.4.349.349 Plzak, 1955, Demonstration of stimulation of erythropoiesis by plasma from anemic rats, using Fe59, J Lab Clin Med, 46, 671 Fried, 1956, Assay of erythropoietin in hypophysectomized rats, Proc Soc Exp Biol Med, 92, 203, 10.3181/00379727-92-22428 Degowin, 1962, The mouse with hypoxia induced erythremia, an erythropoietin assay animal, J Lab Clin Med, 60, 846 Goldwasser, 1957, Mechanism of the erythropoietic effect of cobalt, Science, 125, 1085, 10.1126/science.125.3257.1085 Fried, 1965, Erythropoietic effect of the plasma from mice receiving testosterone, Nature, 206, 1160, 10.1038/2061160a0 Stohlman, 1954, Evidence of a humoral regulation of erythropoiesis: Studies on a patient with polycythemia secondary to regional hypoxia, Blood, 9, 721, 10.1182/blood.V9.7.721.721 Jacobson, 1957, Role of the kidney in erythropoiesis, Nature, 139, 633, 10.1038/179633a0 Miyake, 1977, Purification of human erythropoietin, J Biol Chem, 252, 5558, 10.1016/S0021-9258(19)63387-9 Lin, 1985, Cloning and expression of the human erythropoietin gene, Proc Natl Acad Sci U S A, 82, 7580, 10.1073/pnas.82.22.7580 Krantz, 1984, Specific binding of erythropoietin in spleen cells infected with the anemia strain of Fried virus, Proc Natl Acad Sci U S A, 81, 7574, 10.1073/pnas.81.23.7574 Broudy, 1991, Erythropoietin receptor characteristics on primary human erythroid cells, Blood, 15, 2583, 10.1182/blood.V77.12.2583.2583 McCaffrey, 1989, Subunit structure of the erythropoietin receptor, J Biol Chem, 264, 10507, 10.1016/S0021-9258(18)81650-7 Witthuhn, 1993, JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following EPO stimulation, Cell, 74, 227, 10.1016/0092-8674(93)90414-L Miura, 1994, Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vitro, Blood, 84, 1501, 10.1182/blood.V84.5.1501.1501 Kilbridge, 1968, Response of mice with decreased number of hematopoietic stem cells to doses of erythropoietin, J Lab Clin Med, 72, 85 Stein, 2005, The role of erythropoietin in the anemia of myelodysplastic syndrome, Clin Lymphoma, 6, 52, 10.3816/CLM.2005.n.029 Fisher, 1996, Erythropoietin production by interstitial cells of hypoxic monkey kidneys, Br J Haematol, 95, 27, 10.1046/j.1365-2141.1996.d01-1864.x Koury, 1993, The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver, Microsc Res Tech, 39, 25 Zanjani, 1981, Studies on the liver to kidney switch of erythropoietin production, J Clin Invest, 67, 1183, 10.1172/JCI110133 Fried, 1972, The liver as a source of extrarenal erythropoietin production, Blood, 40, 671, 10.1182/blood.V40.5.671.671 Fried, 1979, Effect of carbon tetrachloride on extrarenal erythropoietin production, J Lab Clin Med, 93, 700 Simon, 1980, Improvement of anemia in hemodialysed patients after viral or toxic hepatic cytolysis, Br Med J, 280, 892, 10.1136/bmj.280.6218.892 Conrad, 1996, Expression of erythropoietin by the human placenta, FASEB J, 10, 760, 10.1096/fasebj.10.7.8635693 Zhang, 1996, Effect of chronic renal failure on the expression of erythropoietin message in a murine model, Exp Hematol, 24, 1469 Burk, 1977, Renal cell carcinoma with erythrocytosis and elevated erythropoietic stimulatory activity, South Med J, 70, 955, 10.1097/00007611-197708000-00017 Scott, 1974, Hepatoma, erythrocytosis, and increased serum erythropoietin developing in long-standing hemochromatosis, Am J Gastroenterol, 61, 206 Suzuki, 2001, Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis, Br J Haematol, 113, 49, 10.1046/j.1365-2141.2001.02682.x Matsuo, 2003, EPO-producing gastric carcinoma in a hemodialysis patient, Am J Kidney Dis, 42, E3, 10.1016/S0272-6386(03)00425-6 Fried, 1957, Studies on erythropoiesis III. Factors controlling erythropoietin production, Proc Soc Exp Biol Med, 94, 241, 10.3181/00379727-94-22910 Goldberg, 1988, Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein, Science, 242, 1412, 10.1126/science.2849206 Wang, 1993, General involvement of hypoxia inducible factor in transcriptional response to hypoxia, Proc Soc Natl Acad Sci U S A, 90, 4304, 10.1073/pnas.90.9.4304 Huang, 1997, Erythropoietin gene regulation depends on heme dependant oxygen sensing and assembly of interacting transcription factors, Kidney Int, 51, 10.1038/ki.1997.76 Kickler, 1989, Repeated blood donations and erythropoietin levels, JAMA, 261, 1443, 10.1001/jama.1989.03420100077021 Mirand, 1965, Mechanism of testosterone action on erythropoiesis, Nature, 206, 270, 10.1038/206270a0 Alexanian, 1967, Erythropoietin excretion in man following androgens, J Lab Clin Med, 70, 777 Doane, 1975, Response of uremic patients to Nandrolone Decanoate, Arch Intern Med, 135, 972, 10.1001/archinte.1975.00330070094015 Jelkmann, 1994, Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states, Ann N Y Acad Sci, 718, 300, 10.1111/j.1749-6632.1994.tb55728.x Krantz, 1994, Pathogenesis and treatment of the anemia of chronic disease, Am J Med Sci, 307, 353, 10.1097/00000441-199405000-00009 Kilbridge, 1969, The mechanism by which plethora suppresses erythropoiesis, Blood, 33, 104, 10.1182/blood.V33.1.104.104 Necas, 1970, Feedback regulation by red cell mass of the sensitivity of the erythropoietin producing organ to hypoxia, Blood, 36, 754, 10.1182/blood.V36.6.754.754 Fried, 1970, Observations on regulation of erythropoiesis during periods of prolonged hypoxia, Blood, 36, 607, 10.1182/blood.V36.5.607.607 Stohlman, 1959, Humoral regulation of erythropoiesis V. Relationship of plasma erythropoietin activity to bone marrow activity, Proc Soc Exp Biol Med, 100, 40, 10.3181/00379727-100-24516 Fried, 1984, Regulation of the plasma erythropoietin level in hypoxic rats, Exp Hematol, 12, 706 Fried, 1971, Regulation of plasma erythropoietin levels in mice with impaired response to erythropoietin, J Lab Clin Med, 78, 48 Naets, 1965, Effect of erythroid hyperplasia on utilization of erythropoietin, Nature, 206, 10.1038/206726a0 Beguin, 1998, Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous stem cell transplant, Haematologia, 83, 1076 Cazzola, 1998, Red blood cell precursor mass as an independent determinant of serum erythropoietin level, Blood, 91, 239, 10.1182/blood.V91.6.2139 de Klerk, 1981, Serum erythropoietin titers in anemia, Blood, 58, 1164, 10.1182/blood.V58.6.1164.1164 Hammond, 1962, The relationship between erythropoietin and severity of anemia in hypoplastic and hemolytic states, 351 Finne, 1965, On the correspondence between red cell production and plasma erythropoietin level, Scand J Clin Lab Invest, 17, 135, 10.3109/00365516509077299 Morgan, 2002, Mechanisms and regulation of intestinal iron absorption, Blood Cells Mol Dis, 29, 384, 10.1006/bcmd.2002.0578 Mims, 2005, Divalent metal transporter 1, Hematology, 10, 339, 10.1080/10245330500093419 Abboud, 2000, A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J Biol Chem, 275, 19906, 10.1074/jbc.M000713200 Donovan, 2005, The iron exporter ferroportin/Sic40a1 is essential for iron homeostasis, Cell Metab, 1, 191, 10.1016/j.cmet.2005.01.003 Park, 2001, Hepcidin, a urinary antimicrobial peptide, synthesized in the liver, J Biol Chem, 276, 7806, 10.1074/jbc.M008922200 Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance, J Clin Invest, 117, 1933, 10.1172/JCI31342 Ganz, 2007, Molecular control of iron transport, J Am Soc Nephrol, 18, 394, 10.1681/ASN.2006070802 Pak, 2006, Suppression of hepcidin during anemia requires erythropoiesis, Blood, 108, 3730, 10.1182/blood-2006-06-028787 Gardeghi, 2007, Ineffective erythropoiesis in (beta) thalassemia is characterized by increased iron absorption mediated by-down regulation of hepcidin and up-regulation of ferroportin, Blood, 109, 5027, 10.1182/blood-2006-09-048868 Pinto, 2008, Erythropoietin mediates hepcidin expression in hepatocytes through OPOR signaling and regulation of C/EBPalpha, Blood, 111, 5727, 10.1182/blood-2007-08-106195 Peyssonnaux, 2007, Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs), J Clin Invest, 117, 1926, 10.1172/JCI31370 Tanno, 2007, High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin, Nat Med, 13, 1096, 10.1038/nm1629 Wrighting, 2006, Interleulin-6 induces hepcidin expression through STAT3, Blood, 108, 3204, 10.1182/blood-2006-06-027631 Schade, 1976, The utilization of senescent re cell and hemolysate iron for erythropoiesis, Proc Soc Exp Biol Med, 151, 78, 10.3181/00379727-151-39147 Eschbach, 1987, Correction of the anemia of end stage renal failure with recombinant human erythropoietin. Results of a combined phase I and II clinical trial, N Engl J Med, 316, 73, 10.1056/NEJM198701083160203 Eschbach, 1989, Recombinant human erythropoietin in anemic patients with end stage renal disease, Ann Intern Med, 111, 992, 10.7326/0003-4819-111-12-992 Origa, 2007, Liver iron concentrations and urinary hepcidin in beta thalassemia, Haematologica, 92, 583, 10.3324/haematol.10842 Cazzola, 2005, Myelodysplastic syndromes—coping with ineffective erythropoiesis, N Engl J Med, 352, 536, 10.1056/NEJMp048266 Gurney, 1957, Studies on erythropoiesis. IV. Erythropoietin in human plasma, J Lab Clin Med, 50, 534 Gallagher, 1959, Evaluation of plasma erythropoietic stimulating factor in anemic uremic patients, Blood, 14, 662, 10.1182/blood.V14.6.662.662 Cotes, 1986, Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis, N Engl J Med, 315, 283, 10.1056/NEJM198607313150503 Ward, 1971, Serum erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease, J Clin Invest, 50, 332, 10.1172/JCI106500 Erslev, 1987, Erythropoietin in anemic non-uremic patients, J Lab Clin Med, 109, 429 Jelkmann, 1990, Serum erythropoietin level: relationship to blood hemoglobin concentration and erythrocytic activity of the bone marrow, J Mol Biol, 68, 403 Berlin, 1997, Polycythemia vera: a retrospective and reprise, J Lab Clin Med, 130, 366, 10.1016/S0022-2143(97)90035-4 James, 2005, A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera, Nature, 434, 1144, 10.1038/nature03546 Tefferi, 2007, Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel, Blood, 110, 1092, 10.1182/blood-2007-04-083501 Winearls, 1986, Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic hemodialysis, Lancet, 2, 1175, 10.1016/S0140-6736(86)92192-6 Means, 1995, Erythropoietin in the treatment of anemia in chronic infectious, inflammatory and malignant diseases, Curr Opin Hematol, 2, 210, 10.1097/00062752-199502030-00009 Rizzo, 2008, Use of epoietin and darbepoietin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update, Blood, 111, 25, 10.1182/blood-2007-08-109488 Mittleman, 1997, Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia, Acta Haematol, 98, 204, 10.1159/000203625 Mundle, 2009, An assessment of erythroid response to epoeitin alpha as a single agent versus in combination with granulocyte or granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach, Cancer, 15, 706, 10.1002/cncr.24090 Casadevail, 2004, Health, economic, and quality-of-life effects of erythropoietin and granulocyte-colony−stimulating-factor for the treatment of myelodysplastic syndromes: a randomized, controlled trail, Blood, 104, 321, 10.1182/blood-2003-07-2252 Henry, 1992, Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and Zidovudine therapy, Ann Intern Med, 117, 739, 10.7326/0003-4819-117-9-739 Goodnough, 1994, A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy, Transfusion, 34, 66, 10.1046/j.1537-2995.1994.34194098608.x Henke, 2003, Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial, Lancet, 362, 1255, 10.1016/S0140-6736(03)14567-9 Leyland-Jones, 2005, Maintaining normal hemoglobin levels with epoietin alfa in mainly nonanemic patients with metastatic breast cancer receiving first line chemotherapy: a survival study, J Clin Oncol, 23, 5960, 10.1200/JCO.2005.06.150 Bennett, 2008, Venous thromboembolism and mortality associated with recombinant erythropoietin and darbopoietin administration for the treatment of cancer associated anemia, JAMA, 299, 914, 10.1001/jama.299.8.914 Fandry, 2008, Erythropoietin receptors on tumor cells: what do they mean, Oncologist, 13, 16, 10.1634/theoncologist.13-S3-16 Ribatti, 2007, erythropoietin/erythropoietin receptor system is involved in angiogenesis in human hepatocellular carcinoma, Histopathology, 50, 591, 10.1111/j.1365-2559.2007.02654.x